Formulation and evaluation of tear substitutes

International Journal of Pharmaceutical Sciences Review and Research

Volumn 2, Issue 1, 2010, Pages 17-20

  Vibhute, Somnath ^a   Kawtikwar, Pravin ^a   Kshirsagar, Sunil ^a   Sakarkar, Dinesh ^a  

^a SN Institute of Pharmacy   (India)

Author keywords

Artificial tears; Dry eye syndrome; Viscosity enhancers and sterility test

Indexed keywords

ARTIFICIAL TEAR; CARBOXYMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 400; POLYVINYL ALCOHOL; POVIDONE; PROPYLENE GLYCOL;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG LABELING; DRUG SCREENING; DRUG STABILITY; DRUG SYNTHESIS; DRY EYE; KERATOCONJUNCTIVITIS SICCA; QUANTITATIVE ANALYSIS; SHELF LIFE; TEAR FILM; VISCOSITY;

EID: 79952031752     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Clinical Knowledge Summaries, Dry eye syndrome, (March 2008), www.patient-pharmacy.co.uk.
2. Dry Eye, Eye Facts, The Eye Digest, www.uic.edu.
3. Dry Eyes, dry eye information centre, www.agingeye.net.
4. Brewitt H, Sistani F, Dry eye disease: The scale of problem, Surv. Ophthalmol. 2001; 45(2), S199-202.
5. Dalzell M., Dry Eye: Prevalence, Utilization and Economic Implications - a peer reviewed compendium of formulary consideration, P&T Digest, vol.28 (12), 2003, 9-13.
6. Lee AJ., et al, Prevalence and risk factors associated with dry eye symptoms: A population based study in Indonesia, Br. J. Ophthalmol, Dec 2002; 86: 1347-1351.
7. Dry eyes, MedlinePlus Medical Encyclopedia. U.S. National Library of Medicine (04/10/2006). Retrieved on 16/11/2006.
8. Tear substitute benefits, Highlights Ophthalmol, Int Ophthalmol Clin 1991, 31: 83-90
9. Lambert DW, Physiology of tear film. In: Smolin G, Thoft RA, eds, The Cornea, 3rd ed. Boston: Little, Brown, 1994, 439-455.
10. James W., Preformulation, in Phaermaceutics: The science of dosage form design, edited by Aulton ME., 2nd edition, Churchill Livingsttone, London, 2002; 113-137.
11. Cartensen JT., Preformulation, in Modern pharmaceutics, edited by Bankar GS., and Rhodes CT., vol.121, 4th edition Marcel Dekker, New York; 2002, 167-186.
12. Reynolds LA, Closson RG, Extemporaneous Ophthalmic Preparations, Vancouver WA, Applied Therapeutics, Inc., 1993.
13. Anon. Ophthalmic Drug Facts 1998. St Louis MO, Facts and Comparisons-A Wolters Kluwer Commpany, 1998.
14. WO/2005/089715): Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose, 2005.
15. The United State Pharmacopoeia United State Pharmacopoeial Covenction, Rockville, MD. Asian Edn. 2000; 1352.
16. Indian Pharmacopoeia, vol. I & II, Govt. of India, Ministry of health and family welfare,The Indian Pharmacopia commision, Controller of publication, New Delhi, 2007, 812.